Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections
- PMID: 31201571
- DOI: 10.1007/s11934-019-0910-8
Outcomes of Surgery in Peyronie's Disease Following Intralesional Collagenase Clostridium Histolyticum Injections
Abstract
Purpose of review: To explore the potential hurdles surgeons may encounter when preforming surgical correction of penile curvature in patients with Peyronie's Disease following intralesional collagenase clostridium histolyticum injections.
Recent findings: Although limited data exists, retrospective analysis of surgeon experiences in surgical treatment of refractory penile curvature in patients with Peyronie's disease appears to not result in more post-operative complications and may only slightly increase intra-operative difficulty. As the use of intralesional collagenase clostridium histolyticum continues to increase and patients who demonstrate persistent curvature despite treatment seek further management, the role of investigating the feasibility of surgery demonstrates significant importance. Although limited data exists, it appears that surgery following intralesional collagenase clostridium histolyticum is safe without added post-operative complications. At the present time, however, further data on intra-operative findings and post-operative outcomes remain necessary, and as the use of this intralesional therapy continues to rise, further information should become readily available.
Keywords: Collagenase clostridium histolyticum; Peyronie’s disease; Reconstructive surgery; Refractory curvature; Sexual medicine; Surgical outcome.
Comment in
-
Re: Outcomes of Surgery in Peyronie's Disease following Intralesional Collagenase Clostridium histolyticum Injections.J Urol. 2020 Jan;203(1):15. doi: 10.1097/01.JU.0000604948.22635.74. Epub 2019 Oct 18. J Urol. 2020. PMID: 31625788 No abstract available.
Similar articles
-
Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.J Sex Med. 2015 Jan;12(1):259-64. doi: 10.1111/jsm.12721. Epub 2014 Oct 27. J Sex Med. 2015. PMID: 25345351
-
Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.J Urol. 2016 Apr;195(4 Pt 1):1051-6. doi: 10.1016/j.juro.2015.10.065. Epub 2015 Oct 23. J Urol. 2016. PMID: 26476353 Clinical Trial.
-
Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.J Urol. 2019 Apr;201(4):777-782. doi: 10.1097/JU.0000000000000032. J Urol. 2019. PMID: 30672843
-
Characteristics predictive of response to collagenase clostridium histolyticum for Peyronie's disease: a review of the literature.World J Urol. 2020 Feb;38(2):279-285. doi: 10.1007/s00345-019-02850-3. Epub 2019 Jun 26. World J Urol. 2020. PMID: 31250098 Review.
-
[Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].Zhonghua Nan Ke Xue. 2017 Sep;23(9):771-775. Zhonghua Nan Ke Xue. 2017. PMID: 29726655 Review. Chinese.
Cited by
-
Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie's disease in a multicenter clinical study.Sci Rep. 2021 Jan 8;11(1):166. doi: 10.1038/s41598-020-80551-3. Sci Rep. 2021. PMID: 33420247 Free PMC article.
-
ESSM Position Statement on Surgical Treatment of Peyronie's Disease.Sex Med. 2022 Feb;10(1):100459. doi: 10.1016/j.esxm.2021.100459. Epub 2021 Nov 22. Sex Med. 2022. PMID: 34823053 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials